|8:00 AM-8:50 AM
Joint Salvage – Excision, Fusion, Replacement. The What, Where, and When Update
The treatment of end-stage joint disease is an ever-changing orthopedic landscape that continues to evolve and develop. The challenge of knowing when to advise joint salvage and the pros and cons of the different options will be clarified to our current level of understanding. The use of joint resurfacing, joint fusion, joint excision, and total replacement will be discussed and the current successful strategies for shoulder, elbow, carpus, hip, stifle, hock, and digit salvage presented.
|9:00 AM-9:50 AM
The Fracture Repair Conundrum – Minimally Invasive (MIPO) vs. Maximal Stability (ORIF). What Has Changed and Why?
As fracture repair has progressed in small animals over the past 50 years, the concept of carpenter vs. gardener has driven many of the current strategies. The introduction of bone plating, its evolution into locking plate technology, and the more recent focus on minimally invasive fracture repair techniques has allowed veterinary orthopedists to seek more rapid healing with less morbidity. The pros and cons of the different approaches will be discussed and considered.
|10:20 AM-11:00 AM
Biologics in Orthopedics – The Options, the Evidence, the Indications
A sweeping change in approach over the past 10 years in both human and veterinary orthopedic care has been the introduction and expansion of biologic therapy. With stem cells being collected from body fat and bone marrow, and platelets and associated growth factors being isolated from blood plasma, the orthopedic world has been awash with recommendations on possible use in small animal patients. A discourse on the current state-of-play in terms of in vitro and in vivo scientific evidence to support biologic agent use and the clinical responses seen with therapy will be presented.